Antibiotic stewardship for early-onset sepsis.

Seminars in Perinatology
Michael W Kuzniewicz, Karen M Puopolo

Abstract

Antibiotics are administered to the vast majority of preterm newborns and to a substantial proportion of term infants in the hours after birth due to risk for early-onset sepsis. The approaches taken to determine which newborns should be evaluated for early-onset sepsis, and what type and duration of antibiotics are administered, are important elements of neonatal antibiotic stewardship. The use of multivariate prediction models for sepsis risk assessment among infants born ≥35 weeks' gestation can safely reduce the use of empiric antibiotic therapy. Approaches incorporating serial physical examination may also contribute to decreasing empiric antibiotic exposure among such infants. Among infants born <35 weeks' gestation, delivery characteristics can be used to identify preterm infants at low enough risk of early infection that empiric therapies are not required. Data informing the epidemiology, microbiology and antibiotic susceptibility patterns of early-onset sepsis pathogens can be used to optimize antibiotic choice for empiric and targeted antibiotic therapy to ensure that effective therapies are administered, while decreasing the risks associated with broad-spectrum antibiotic exposure. Optimal use of blood culture and ti...Continue Reading

References

Nov 18, 1998·Journal of Clinical Microbiology·J SpaargarenG P Voorn
Jun 10, 2011·The Pediatric Infectious Disease Journal·Emily J WestonStephanie J Schrag
Mar 1, 2012·Pediatrics·UNKNOWN Section on Breastfeeding
Nov 28, 2012·Seminars in Perinatology·Sagori Mukhopadhyay, Karen M Puopolo
Dec 25, 2013·Pediatrics·Gabriel J EscobarDavid Draper
Jan 22, 2014·Pediatrics·Sagori MukhopadhyayKaren M Puopolo
Jul 19, 2014·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Alberto BerardiFabrizio Ferrari
Sep 9, 2015·JAMA : the Journal of the American Medical Association·Barbara J StollUNKNOWN Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
Sep 29, 2015·BJOG : an International Journal of Obstetrics and Gynaecology·M B AzadUNKNOWN CHILD Study Investigators
Jun 17, 2016·Science Translational Medicine·Nicholas A BokulichMartin J Blaser
Dec 13, 2016·Pediatrics·Stephanie J SchragRuth Lynfield
Feb 28, 2017·JAMA Pediatrics·Michael W KuzniewiczGabriel J Escobar
Aug 15, 2017·JAMA Pediatrics·Michael W KuzniewiczKaren M Puopolo
Sep 14, 2017·JAMA : the Journal of the American Medical Association·Chanu RheeUNKNOWN CDC Prevention Epicenter Program
Oct 7, 2017·Pediatrics·Karen M PuopoloUNKNOWN NICHD Neonatal Research Network
Feb 20, 2018·European Journal of Pediatrics·Niek B AchtenFrans B Plötz
Feb 24, 2018·American Journal of Perinatology·Joseph Y TingUNKNOWN Canadian Neonatal Network and Canadian Neonatal Follow-Up Network
Apr 19, 2018·Hospital Pediatrics·Miren B DhudasiaKaren M Puopolo
Jan 16, 2019·JAMA Network Open·Dustin D FlanneryJeffrey S Gerber
Feb 10, 2019·Pediatric Research·Rachel G GreenbergUNKNOWN Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
Mar 2, 2019·Pediatrics·Joseph Y TingUNKNOWN Canadian Neonatal Network Investigators
Dec 7, 2019·Archives of Disease in Childhood. Fetal and Neonatal Edition·Karen M Puopolo
May 8, 2020·The Pediatric Infectious Disease Journal·Michael W KuzniewiczKaren M Puopolo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.